Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Neuromed Pharmaceuticals
company
About
Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $32M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States.Neuromed Pharmaceuticals was acquired by Zalicus in December 2009.Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$57M
Neuromed Pharmaceuticals has raised a total of
$57M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2006 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2006 | Series D | $25M | 1 | — | — | Detail |
| Nov 4, 2003 | Series C | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Neuromed Pharmaceuticals is funded by 1 investors.
Cogene Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
